04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
On April 16, 2020, sixteen California legislators urged Bay Area counties to relax the restrictions ...
Read More >
On December 18, 2019, Cal/OSHA issued a news release outlining California’s fatal workplace injury ...
Read More >
The Fifth Circuit concluded that a plan participant was not entitled to recover attorneys’ fees for...
Read More >
Employers make their own luck. When it comes to terminations of employment, are you lucky or unluck...
Read More >
I want to emphasize again the risks JVs pose under the FCPA. Mike Volkov has stated, “A joint ventu...
Read More >
Earlier this month New Jersey enacted the comprehensive Anti-Wage Theft Law (the “Act”), which ame...
Read More >